UK markets closed

TaiMed Biologics Inc. (4147.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
87.70+0.80 (+0.92%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
598,958
491,777
563,008
413,442
722,485
Cost of revenue
350,437
266,544
347,297
329,487
401,244
Gross profit
248,521
225,233
215,711
83,955
321,241
Operating expenses
Research development
303,970
294,278
333,121
460,600
394,449
Selling general and administrative
76,688
97,186
74,446
109,722
59,552
Total operating expenses
380,658
391,464
407,567
570,322
454,001
Operating income or loss
-132,137
-166,231
-191,856
-486,367
-132,760
Interest expense
14,985
14,813
10,099
7,444
4,088
Income before tax
-130,044
-194,810
-269,289
-470,933
-183,304
Income tax expense
0
0
0
0
0
Income from continuing operations
-130,044
-194,810
-269,289
-470,933
-183,304
Net income
-130,044
-194,810
-269,289
-470,933
-183,304
Net income available to common shareholders
-130,044
-194,810
-269,289
-470,933
-183,304
Basic EPS
-0.68
-0.76
-1.05
-1.84
-0.72
Diluted EPS
-0.68
-0.76
-1.05
-1.84
-0.72
Basic average shares
252,691
256,501
256,043
255,940
255,871
Diluted average shares
252,691
256,501
256,043
255,940
255,871